2020
DOI: 10.1038/s41598-020-58968-7
|View full text |Cite
|
Sign up to set email alerts
|

Genome-wide screening of lipoproteins in Actinobacillus pleuropneumoniae identifies three antigens that confer protection against virulent challenge

Abstract: Actinobacillus pleuropneumoniae is an important veterinary pathogen that causes porcine pleuropneumonia. Lipoproteins of bacterial pathogens play pleiotropic roles in the infection process. In addition, many bacterial lipoproteins are antigenic and immunoprotective. Therefore, characterization of lipoproteins is a promising strategy for identification of novel vaccine candidates or diagnostic markers. We cloned 58 lipoproteins from A. pleuropneumoniae JL03 (serovar 3) and expressed them in Escherichia coli. Fi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 43 publications
0
4
0
Order By: Relevance
“…Referring to the severity of symptoms caused by A. pleuropneumoniae and based on the assumption of a high A. pleuropneumoniae prevalence (>0.3), Stygar and coworkers calculated the additional yearly costs between €0.4 and 24 per space unit (Stygar et al, 2016 ). Due to the challenges of antibiotic usage and the generation of antibiotic resistance, the most promising approach to preventing A. pleuropneumoniae infection lies in vaccination (Cao et al, 2020 ; Michael et al, 2015 ). Current market‐leading vaccines are based on inactivated Apx toxins and outer membrane components of A. pleuropneumoniae or inactivated A. pleuropneumoniae of selected serovars (Del Pozo Sacristán et al, 2014 ; Sipos et al, 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…Referring to the severity of symptoms caused by A. pleuropneumoniae and based on the assumption of a high A. pleuropneumoniae prevalence (>0.3), Stygar and coworkers calculated the additional yearly costs between €0.4 and 24 per space unit (Stygar et al, 2016 ). Due to the challenges of antibiotic usage and the generation of antibiotic resistance, the most promising approach to preventing A. pleuropneumoniae infection lies in vaccination (Cao et al, 2020 ; Michael et al, 2015 ). Current market‐leading vaccines are based on inactivated Apx toxins and outer membrane components of A. pleuropneumoniae or inactivated A. pleuropneumoniae of selected serovars (Del Pozo Sacristán et al, 2014 ; Sipos et al, 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…A. pleuropneumoniae is considered one of the most important bacterial respiratory pathogens of pigs with epidemic disease resulting in serious economic loss ( 36 ). There are many studies on the infection mechanism and the resistance to environmental pressure of A. pleuropneumoniae , but there are still many unknowns to be researched.…”
Section: Discussionmentioning
confidence: 99%
“…Because a single protein may lack epitopes suitable for universal immune recognition, it cannot be used against all serotypes of A. pleuropneumoniae. Multiple antigens induce stronger immune responses than those triggered by a single component [14]. This is our strategy immunization with subunit vaccines combined with individual potential structural and functional proteins from the same target would be predicted to trigger the development of a strong host protective immune response.…”
Section: Introductionmentioning
confidence: 99%